Sensitivity and Specificity of the Boston Criteria Version 2.0 for the Diagnosis of Cerebral Amyloid Angiopathy in a Community-Based Sample.
Maria Clara Zanon ZotinNazanin MakkinejadJulie A SchneiderKonstantinos ArfanakisCharidimou AndreasSteven M GreenbergSusanne J van VeluwPublished in: Neurology (2023)
This study provides Class II evidence that the Boston criteria v2.0 accurately distinguishes people with CAA from those without CAA.